- Query in any language with multilingual search
- Access EUR-Lex and EU Commission case law
- See relevant paragraphs highlighted instantly
Similar Documents
Explore similar documents to your case.We Found Similar Cases for You
Case C-259/22 P: Judgment of the Court (Eighth Chamber) of 22 June 2023 — Arysta LifeScience Great Britain Ltd v European Commission, Taminco BVBA (Appeal — Plant protection products — Active substance — Regulation (EC) No 1107/2009 — Article 4(5) — Article 14(1) — Article 20(1) — Implementing Regulation (EU) No 844/2012 — Article 12(3) — Article 14(1) — Non-renewal of the approval of the active substance thiram for the purpose of placing it on the market — Rights of the defence — Precautionary principle — Equal treatment)
ECLI:EU:UNKNOWN:62022CA0259
62022CA0259
With us you find everything. Try it now!
I imagine what I want to write in my case, I write it in the search engine and I get exactly what I wanted. Thank you!
Valentina R., lawyer
Official Journal of the European Union
C 278/11
(Case C-259/22 P) (1)
(Appeal - Plant protection products - Active substance - Regulation (EC) No 1107/2009 - Article 4(5) - Article 14(1) - Article 20(1) - Implementing Regulation (EU) No 844/2012 - Article 12(3) - Article 14(1) - Non-renewal of the approval of the active substance thiram for the purpose of placing it on the market - Rights of the defence - Precautionary principle - Equal treatment)
(2023/C 278/15)
Language of the case: English
Parties
Appellant: Arysta LifeScience Great Britain Ltd (represented by: C. Mereu, avocat)
Other parties to the proceedings: European Commission, (represented by G. Koleva and M. ter Haar, acting as Agents), Taminco BVBA (represented by: C. Mereu, avocat)
Operative part of the judgment
The Court:
1.Dismisses the appeal;
2.Orders Arysta LifeScience Great Britain Ltd to pay the costs.
OJ C 222, 7.6.2022.
Language of the case: English